Covid-19 to reduce (re)insurers’ insurtech capital allocation
The coronavirus crisis is likely to lead insurers and reinsurers to pull back on insurtech investments, both in terms of the number of deals and size of investments.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below